investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Epigenetic mechanisms of drug resistance in T-cell acute lymphoblastic leukemia
Birgit Knoechel
0 Collaborator(s)
Funding source
National Institutes of Health (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Birgit Knoechel
Dana-Farber Cancer Institute
Boston, United States
Related projects
Marc Nicklaus
In Silico Screening for Cancer Targets
Leukaemia
Pathology
Hematology and hematologic malignancies
Julie Aurore Losman
The Role of EglN1 and HIF in Normal Hematopoiesis and in Leukemia
Leukaemia
Scott Moore Carlson
The role of PRDM1 in epigenetic regulation and tumor suppression
Leukaemia
Kapil Bhalla
Novel Targeted Therapy for AML
Leukaemia
Amy Paguirigan
Connecting Single Cell Heterogeneity to Clinical Descriptors of Clonal Evolution in Acute Myeloid Leukemia
Leukaemia
Hongbo Chi
Tsc1/mTOR axis in immune homeostasis and tumorigenesis
Leukaemia
David H Haussler
Center for Big Data in Translational Genomics
Leukaemia
Katerina V Gurova
Modulation of cancer specific transcriptional factors with small molecules
Leukaemia
Edward W Harhaj
Mechanisms of HTLV-I Tax Mediated NF-kB Activation
Leukaemia
Pathology
Hematology and hematologic malignancies